AusCann Group Holdings Ltd (ACNNF)
0.005
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
AusCann Group Holdings Enterprise Value: -0.2844M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | -0.2844M |
May 30, 2024 | -0.2844M |
May 29, 2024 | -0.2844M |
May 28, 2024 | -0.2844M |
May 24, 2024 | -0.2844M |
May 23, 2024 | -0.2844M |
May 22, 2024 | 3.020M |
May 21, 2024 | -0.2844M |
May 20, 2024 | 4.738M |
May 17, 2024 | 4.738M |
May 16, 2024 | 4.738M |
May 15, 2024 | 4.738M |
May 14, 2024 | -0.3285M |
May 13, 2024 | -0.3285M |
May 10, 2024 | -0.3285M |
May 09, 2024 | -0.3285M |
May 08, 2024 | -0.3285M |
May 07, 2024 | -0.3285M |
May 06, 2024 | -0.3285M |
May 03, 2024 | -0.3285M |
May 02, 2024 | -0.3285M |
May 01, 2024 | -0.2844M |
April 30, 2024 | 4.760M |
April 29, 2024 | 4.760M |
April 26, 2024 | 4.760M |
Date | Value |
---|---|
April 25, 2024 | 4.760M |
April 24, 2024 | 4.760M |
April 23, 2024 | -0.3285M |
April 22, 2024 | -0.3285M |
April 19, 2024 | -0.3285M |
April 18, 2024 | -0.3285M |
April 17, 2024 | -0.3285M |
April 16, 2024 | -0.3285M |
April 15, 2024 | -0.3285M |
April 12, 2024 | 7.183M |
April 11, 2024 | 7.183M |
April 10, 2024 | 7.183M |
April 09, 2024 | 7.183M |
April 08, 2024 | 7.183M |
April 05, 2024 | -0.5047M |
April 04, 2024 | -0.5047M |
April 03, 2024 | -0.6809M |
April 02, 2024 | -0.6809M |
April 01, 2024 | -0.6809M |
March 28, 2024 | -0.6809M |
March 27, 2024 | -0.5047M |
March 26, 2024 | -0.5047M |
March 25, 2024 | -0.5047M |
March 22, 2024 | -0.5047M |
March 21, 2024 | -0.5047M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.156M
Minimum
Sep 19 2023
86.45M
Maximum
Jul 30 2019
16.23M
Average
15.40M
Median
Dec 08 2021
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 4.672M |
Immutep Ltd | -- |
Opthea Ltd | 72.43M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | 6.72% |
Normalized Earnings Yield | -810.50 |